Back to results
CompletedPhase 1

Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)

NCT00411580

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novartis Investigative Site

Malmö, Sweden

+2 additional locations

View on ClinicalTrials.gov
Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD) — TrialFind